Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hamartoma Syndrome, Multiple | 3 | 2024 | 114 | 0.570 |
Why?
|
Fish Oils | 7 | 2019 | 483 | 0.540 |
Why?
|
Thyroid Neoplasms | 8 | 2024 | 2332 | 0.490 |
Why?
|
Parenteral Nutrition | 6 | 2019 | 659 | 0.460 |
Why?
|
Fat Emulsions, Intravenous | 4 | 2019 | 314 | 0.440 |
Why?
|
Soybean Oil | 6 | 2019 | 139 | 0.340 |
Why?
|
Pathology, Clinical | 2 | 2016 | 376 | 0.310 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2008 | 25 | 0.300 |
Why?
|
Protective Agents | 2 | 2019 | 150 | 0.300 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2008 | 60 | 0.290 |
Why?
|
Fatty Liver | 5 | 2019 | 787 | 0.280 |
Why?
|
Salivary Gland Neoplasms | 2 | 2022 | 304 | 0.270 |
Why?
|
Adenoma | 3 | 2010 | 2159 | 0.220 |
Why?
|
Fatty Acids, Essential | 3 | 2014 | 97 | 0.220 |
Why?
|
Docosahexaenoic Acids | 4 | 2016 | 907 | 0.220 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2019 | 610 | 0.210 |
Why?
|
Awards and Prizes | 1 | 2007 | 360 | 0.200 |
Why?
|
Immunohistochemistry | 10 | 2024 | 11069 | 0.200 |
Why?
|
Ki-67 Antigen | 3 | 2016 | 627 | 0.190 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2022 | 89 | 0.190 |
Why?
|
Endocrinology | 1 | 2007 | 442 | 0.180 |
Why?
|
Arachidonic Acid | 2 | 2012 | 427 | 0.180 |
Why?
|
alpha-Tocopherol | 1 | 2019 | 126 | 0.160 |
Why?
|
Pituitary Neoplasms | 3 | 2014 | 1323 | 0.150 |
Why?
|
PTEN Phosphohydrolase | 1 | 2024 | 1113 | 0.150 |
Why?
|
Paraganglioma | 2 | 2009 | 142 | 0.140 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 262 | 0.130 |
Why?
|
PPAR gamma | 1 | 2019 | 484 | 0.130 |
Why?
|
Hydroxamic Acids | 2 | 2010 | 481 | 0.120 |
Why?
|
Genes, p16 | 1 | 2015 | 160 | 0.120 |
Why?
|
Adrenocortical Carcinoma | 1 | 2016 | 88 | 0.120 |
Why?
|
Pyrvinium Compounds | 1 | 2014 | 3 | 0.120 |
Why?
|
Endotoxemia | 1 | 2016 | 196 | 0.120 |
Why?
|
Disease Models, Animal | 12 | 2019 | 18221 | 0.120 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2016 | 161 | 0.120 |
Why?
|
Hypoglycemia | 2 | 2016 | 883 | 0.120 |
Why?
|
Mice, Inbred C57BL | 16 | 2019 | 22115 | 0.120 |
Why?
|
Pituitary Gland, Anterior | 1 | 2014 | 142 | 0.110 |
Why?
|
Adrenal Cortex | 1 | 2014 | 134 | 0.110 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2010 | 323 | 0.110 |
Why?
|
Hemangiosarcoma | 1 | 2015 | 215 | 0.110 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2014 | 224 | 0.110 |
Why?
|
In Situ Hybridization | 1 | 2017 | 1900 | 0.110 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2014 | 218 | 0.100 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2015 | 455 | 0.100 |
Why?
|
Interleukin-6 | 2 | 2016 | 3206 | 0.100 |
Why?
|
Sulfonamides | 2 | 2015 | 1977 | 0.100 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2012 | 175 | 0.090 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2012 | 125 | 0.090 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1250 | 0.090 |
Why?
|
Lipopolysaccharides | 2 | 2016 | 2202 | 0.090 |
Why?
|
Gene Dosage | 1 | 2015 | 1217 | 0.090 |
Why?
|
Carcinoma | 2 | 2015 | 2327 | 0.090 |
Why?
|
Bone Development | 1 | 2014 | 470 | 0.090 |
Why?
|
Papillomaviridae | 1 | 2017 | 1117 | 0.090 |
Why?
|
Hypocalcemia | 1 | 2012 | 200 | 0.090 |
Why?
|
Triglycerides | 2 | 2016 | 2459 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 988 | 0.090 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2015 | 732 | 0.090 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2010 | 65 | 0.090 |
Why?
|
Dietary Supplements | 2 | 2014 | 3411 | 0.090 |
Why?
|
Parathyroidectomy | 1 | 2012 | 242 | 0.090 |
Why?
|
Thioglycosides | 1 | 2009 | 8 | 0.090 |
Why?
|
Carcinoma, Basal Cell | 1 | 2015 | 557 | 0.080 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2022 | 1608 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 546 | 0.080 |
Why?
|
Liver Diseases | 1 | 2017 | 1297 | 0.080 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2009 | 45 | 0.080 |
Why?
|
Cholestasis, Extrahepatic | 1 | 2008 | 52 | 0.080 |
Why?
|
Carcinoma, Papillary | 2 | 2015 | 785 | 0.080 |
Why?
|
Liver Failure | 1 | 2011 | 250 | 0.080 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2008 | 43 | 0.080 |
Why?
|
RNA, Viral | 1 | 2017 | 2838 | 0.080 |
Why?
|
Bone Diseases, Metabolic | 1 | 2012 | 409 | 0.080 |
Why?
|
Chromogranin A | 1 | 2008 | 47 | 0.080 |
Why?
|
Cholestasis | 1 | 2011 | 378 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2015 | 2057 | 0.070 |
Why?
|
Galectin 3 | 1 | 2009 | 240 | 0.070 |
Why?
|
Translocation, Genetic | 2 | 2022 | 1392 | 0.070 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2009 | 349 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2024 | 5304 | 0.070 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2016 | 1390 | 0.070 |
Why?
|
Indoles | 1 | 2015 | 1830 | 0.070 |
Why?
|
Phospholipids | 1 | 2011 | 786 | 0.070 |
Why?
|
Hepatitis | 1 | 2008 | 228 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4341 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3634 | 0.070 |
Why?
|
Calcitonin | 1 | 2008 | 329 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2010 | 753 | 0.070 |
Why?
|
Keratins | 1 | 2008 | 498 | 0.070 |
Why?
|
Societies | 1 | 2007 | 107 | 0.070 |
Why?
|
Dietary Carbohydrates | 2 | 2012 | 891 | 0.070 |
Why?
|
Neovascularization, Pathologic | 2 | 2015 | 2644 | 0.060 |
Why?
|
Heart Neoplasms | 1 | 2009 | 362 | 0.060 |
Why?
|
Achievement | 1 | 2007 | 288 | 0.060 |
Why?
|
PPAR alpha | 1 | 2006 | 175 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1611 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2801 | 0.060 |
Why?
|
Thyrotropin | 1 | 2008 | 834 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2270 | 0.060 |
Why?
|
Animals | 20 | 2019 | 168201 | 0.060 |
Why?
|
Cell Nucleus | 2 | 2015 | 2894 | 0.060 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2024 | 191 | 0.060 |
Why?
|
Male | 25 | 2024 | 360358 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12966 | 0.050 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2005 | 361 | 0.050 |
Why?
|
Mice | 14 | 2019 | 81368 | 0.050 |
Why?
|
Thyroid Nodule | 1 | 2010 | 764 | 0.050 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1023 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2024 | 257 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2024 | 214 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4020 | 0.050 |
Why?
|
Emulsions | 2 | 2014 | 152 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2017 | 2894 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13635 | 0.050 |
Why?
|
Middle Aged | 14 | 2024 | 220584 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2014 | 2044 | 0.050 |
Why?
|
Hepatocytes | 1 | 2008 | 1231 | 0.050 |
Why?
|
Intestinal Obstruction | 1 | 2005 | 432 | 0.050 |
Why?
|
Eicosapentaenoic Acid | 2 | 2016 | 561 | 0.050 |
Why?
|
Adult | 14 | 2024 | 220969 | 0.050 |
Why?
|
Skin Neoplasms | 2 | 2024 | 5812 | 0.050 |
Why?
|
Thyroid Gland | 1 | 2008 | 1170 | 0.050 |
Why?
|
Blood Vessels | 1 | 2006 | 1113 | 0.050 |
Why?
|
Bone Density | 1 | 2014 | 3548 | 0.050 |
Why?
|
In Situ Nick-End Labeling | 2 | 2015 | 613 | 0.050 |
Why?
|
History, 21st Century | 1 | 2007 | 1565 | 0.040 |
Why?
|
Cell Movement | 1 | 2012 | 5200 | 0.040 |
Why?
|
Pneumonectomy | 1 | 2006 | 1119 | 0.040 |
Why?
|
Aged | 11 | 2024 | 169042 | 0.040 |
Why?
|
Phytosterols | 1 | 2019 | 55 | 0.040 |
Why?
|
Enteral Nutrition | 1 | 2005 | 794 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2005 | 1340 | 0.040 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2019 | 85 | 0.040 |
Why?
|
History, 20th Century | 1 | 2007 | 2764 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 858 | 0.040 |
Why?
|
Humans | 25 | 2024 | 760617 | 0.040 |
Why?
|
Female | 17 | 2024 | 392148 | 0.040 |
Why?
|
DNA Probes, HPV | 1 | 2017 | 21 | 0.040 |
Why?
|
RNA Probes | 1 | 2017 | 111 | 0.040 |
Why?
|
Fixatives | 1 | 2017 | 90 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2008 | 2637 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9172 | 0.040 |
Why?
|
Liver | 4 | 2016 | 7512 | 0.030 |
Why?
|
Gastric Bypass | 1 | 2005 | 818 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2017 | 102 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2017 | 302 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2017 | 241 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 801 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2006 | 3492 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5034 | 0.030 |
Why?
|
Formaldehyde | 1 | 2017 | 357 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2024 | 80566 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2015 | 2509 | 0.030 |
Why?
|
Cell Survival | 2 | 2015 | 5780 | 0.030 |
Why?
|
Pyrazoles | 1 | 2005 | 2008 | 0.030 |
Why?
|
Transcription Factors | 3 | 2022 | 12116 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2006 | 4433 | 0.030 |
Why?
|
Apoptosis | 4 | 2015 | 9476 | 0.030 |
Why?
|
Kidney | 1 | 2010 | 7045 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 550 | 0.030 |
Why?
|
Lipids | 1 | 2005 | 3332 | 0.030 |
Why?
|
Deficiency Diseases | 1 | 2014 | 74 | 0.030 |
Why?
|
Postprandial Period | 1 | 2016 | 314 | 0.030 |
Why?
|
Lung | 2 | 2016 | 9998 | 0.030 |
Why?
|
Parenteral Nutrition, Total | 1 | 2014 | 304 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2014 | 403 | 0.030 |
Why?
|
Trans-Activators | 1 | 2022 | 2852 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2014 | 1058 | 0.020 |
Why?
|
Drug Repositioning | 1 | 2014 | 233 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 717 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2014 | 455 | 0.020 |
Why?
|
Dietary Fats | 2 | 2012 | 1995 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1827 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2022 | 5789 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2012 | 393 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1835 | 0.020 |
Why?
|
Insulin | 1 | 2005 | 6593 | 0.020 |
Why?
|
Plant Oils | 1 | 2011 | 198 | 0.020 |
Why?
|
Growth | 1 | 2012 | 365 | 0.020 |
Why?
|
Mice, SCID | 1 | 2015 | 2625 | 0.020 |
Why?
|
Weight Gain | 2 | 2014 | 2350 | 0.020 |
Why?
|
Thiogalactosides | 1 | 2009 | 7 | 0.020 |
Why?
|
Spleen | 1 | 2016 | 2286 | 0.020 |
Why?
|
Diet, Fat-Restricted | 1 | 2012 | 329 | 0.020 |
Why?
|
Mutation | 3 | 2024 | 30016 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2606 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15612 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1739 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2016 | 1397 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2012 | 540 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2017 | 64568 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1646 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11736 | 0.020 |
Why?
|
Animal Feed | 1 | 2008 | 112 | 0.020 |
Why?
|
Osteoblasts | 1 | 2014 | 1141 | 0.020 |
Why?
|
Common Bile Duct | 1 | 2008 | 106 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3800 | 0.020 |
Why?
|
3-Iodobenzylguanidine | 1 | 2009 | 114 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20074 | 0.020 |
Why?
|
Infant | 2 | 2008 | 36152 | 0.020 |
Why?
|
Biliary Atresia | 1 | 2008 | 88 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2008 | 216 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2747 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 459 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5766 | 0.020 |
Why?
|
Ligation | 1 | 2008 | 447 | 0.020 |
Why?
|
Pituitary Gland | 1 | 2010 | 635 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2009 | 426 | 0.020 |
Why?
|
Femur | 1 | 2014 | 1307 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6074 | 0.020 |
Why?
|
Child, Preschool | 2 | 2008 | 42188 | 0.020 |
Why?
|
Ubiquitination | 1 | 2012 | 1006 | 0.020 |
Why?
|
Membrane Lipids | 1 | 2008 | 252 | 0.020 |
Why?
|
Food, Fortified | 1 | 2008 | 189 | 0.020 |
Why?
|
Caspase 3 | 1 | 2009 | 731 | 0.020 |
Why?
|
Drug Evaluation | 1 | 2008 | 641 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3777 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2009 | 478 | 0.020 |
Why?
|
Drug Approval | 1 | 2014 | 812 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2015 | 1852 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2009 | 283 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2010 | 632 | 0.020 |
Why?
|
Prolactin | 1 | 2008 | 625 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2012 | 808 | 0.020 |
Why?
|
Dumping Syndrome | 1 | 2005 | 18 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3087 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54360 | 0.020 |
Why?
|
Diazoxide | 1 | 2005 | 52 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10754 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4110 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2014 | 1201 | 0.020 |
Why?
|
Drug Synergism | 1 | 2009 | 1755 | 0.020 |
Why?
|
Molecular Structure | 1 | 2009 | 1878 | 0.020 |
Why?
|
Gestational Age | 1 | 2014 | 3577 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6762 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4910 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2570 | 0.020 |
Why?
|
Octreotide | 1 | 2005 | 154 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9586 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2006 | 592 | 0.010 |
Why?
|
Diet Therapy | 1 | 2005 | 151 | 0.010 |
Why?
|
Young Adult | 3 | 2017 | 59179 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2012 | 16967 | 0.010 |
Why?
|
Creatinine | 1 | 2010 | 1896 | 0.010 |
Why?
|
Necrosis | 1 | 2008 | 1610 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2006 | 673 | 0.010 |
Why?
|
Tissue Adhesions | 1 | 2005 | 218 | 0.010 |
Why?
|
Energy Intake | 1 | 2011 | 2132 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2830 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2006 | 1703 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14389 | 0.010 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2004 | 350 | 0.010 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2004 | 361 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3356 | 0.010 |
Why?
|
Incidence | 2 | 2012 | 21337 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4269 | 0.010 |
Why?
|
Doxorubicin | 1 | 2009 | 2224 | 0.010 |
Why?
|
Signal Transduction | 2 | 2019 | 23416 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6338 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2004 | 658 | 0.010 |
Why?
|
Hyperplasia | 1 | 2005 | 1150 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2016 | 3954 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9529 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58894 | 0.010 |
Why?
|
Pancreatectomy | 1 | 2005 | 811 | 0.010 |
Why?
|
Random Allocation | 1 | 2005 | 2392 | 0.010 |
Why?
|
Zebrafish | 1 | 2012 | 3007 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15251 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13441 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2005 | 1624 | 0.010 |
Why?
|
Central Nervous System Neoplasms | 1 | 2008 | 915 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9345 | 0.010 |
Why?
|
Probability | 1 | 2005 | 2475 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2014 | 26180 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2849 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17629 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2006 | 1349 | 0.010 |
Why?
|
Aneuploidy | 1 | 2003 | 552 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5863 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12043 | 0.010 |
Why?
|
Child | 3 | 2016 | 80079 | 0.010 |
Why?
|
Pancreas | 1 | 2005 | 1690 | 0.010 |
Why?
|
Adolescent | 3 | 2016 | 88234 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2008 | 1926 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11874 | 0.010 |
Why?
|
Reference Values | 1 | 2005 | 4919 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 2003 | 1125 | 0.010 |
Why?
|
Regeneration | 1 | 2006 | 1505 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2024 | 20988 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2012 | 18937 | 0.010 |
Why?
|
Echocardiography | 1 | 2009 | 4987 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2009 | 36402 | 0.010 |
Why?
|
Neoplasms | 1 | 2004 | 22131 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18381 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3527 | 0.010 |
Why?
|
Diet | 1 | 2012 | 8048 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17878 | 0.010 |
Why?
|
Rats | 1 | 2009 | 23717 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 3447 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6483 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15828 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2006 | 10432 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39063 | 0.010 |
Why?
|
Survival Rate | 1 | 2004 | 12719 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14648 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2003 | 11116 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2009 | 20556 | 0.000 |
Why?
|